Pericyte-derived glial cell line-derived neurotrophic factor increase the expression of claudin-5 in the blood-brain barrier and the blood-nerve barrier

Neurochemical Research

Volumn 37, Issue 2, 2012, Pages 401-409

  Shimizu, Fumitaka ^a   Sano, Yasuteru ^a   Saito, Kazuyuki ^b   Abe, Masa Aki ^a   Maeda, Toshihiko ^a   Haruki, Hiroyo ^a   Kanda, Takashi ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Blood brain barrier; Blood nerve barrier; Endothelial cells; GDNF; Pericytes

Indexed keywords

CLAUDIN 5; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

ARTICLE; BLOOD BRAIN BARRIER; BLOOD NERVE BARRIER; BRAIN FUNCTION; CONTROLLED STUDY; ELECTRIC RESISTANCE; HUMAN; HUMAN CELL; MICROVASCULAR ENDOTHELIAL CELL; NERVE REGENERATION; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; UPREGULATION;

ANTIBODIES, NEUTRALIZING; BASE SEQUENCE; BLOOD-BRAIN BARRIER; BLOOD-NERVE BARRIER; BLOTTING, WESTERN; CELL LINE, TRANSFORMED; CLAUDINS; DNA PRIMERS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; PERICYTES; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84856373406     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-011-0626-8     Document Type: Article

References (44)

1. Poduslo JF, Curran GL, Berg CT (1994) Macromolecular permeability across the blood-nerve and blood-brain barriers. Proc Natl Acad Sci USA 91:5705-5709 (Pubitemid 24174397)
2. Engelhardt B (2010) T cell migration into the central nervous system during health and disease: Different molecular keys allow access to different central nervous system compartments. Clin Exp Neuroimmunol 1:79-93
3. Sano Y, Shimizu F, Nakayama H et al (2008) Endothelial cells constituting blood-nerve barrier have highly specialized characteristics as barrier-forming cells. Cell Struct Funct 32:139-147 (Pubitemid 351483586)
4. Hori S, Ohtsuki S, Hosoya K et al (2004) A pericyte-derived angiopoietin-1 multimeric complex induces occludin gene expression in brain capillary endothelial cells through Tie-2 activation in vitro. J Neurochem 89:503-513 (Pubitemid 38495998)
5. Kim JH, Kim JH, Park JA et al (2006) Blood-neural barrier: intercellular communication at glio-vascular interface. J Biochem Mol Biol 39:339-345
6. Shimizu F, Sano Y, Maeda T et al (2008) Peripheral nerve pericytes originating from the blood-nerve barrier expresses tight junctional molecules and transporters as barrier-forming cells. J Cell Physiol 217:388-399
7. Shimizu F, Sano Y, Abe MA et al (2011) Peripheral nerve pericytes modify the blood-nerve barrier function and tight junctional molecules through the secretion of various soluble factors. J Cell Physiol 226:255-266
8. Sariola H, Saarma M (2003) Novel functions and signalling pathways for GDNF. J Cell Sci 116:3855-3862 (Pubitemid 37279301)
9. Gill SS, Patel NK, Hotton GR et al (2003) Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 9:589-595 (Pubitemid 36597106)
10. Sherer TB, Fiske BK, Svendsen CN et al (2006) Crossroads in GDNF therapy for Parkinson's disease. Mov Disord 21:136-141
11. Wang LJ, Lu YY, Muramatsu S et al (2002) Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis. J Neurosci 22:6920-6928 (Pubitemid 35379150)
12. Klein SM, Behrstock S, McHugh J et al (2005) GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum Gene Ther 16:509-521 (Pubitemid 40647148)
13. Boyd JG, Gordon T (2003) Glial cell line-derived neurotrophic factor and brain-derived neurotrophic factor sustain the axonal regeneration of chronically axotomized motoneurons in vivo. Exp Neurol 183:610-619 (Pubitemid 37205103)
14. Mizuta I, Ohta M, Ohta K et al (2001) Riluzole stimulates nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis in cultured mouse astrocytes. Neurosci Lett 310:117-120 (Pubitemid 32822818)
15. Wang Y, Chang CF, Morales M et al (2002) Protective effects of glial cell line-derived neurotrophic factor in ischemic brain injury. Ann NY Acad Sci 962:423-437 (Pubitemid 34592330)
16. Bruno V, Battaglia G, Copani A et al (2001) Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs. J Cereb Blood Flow Metab 21:1013-1033 (Pubitemid 32823739)
17. Utsumi H, Chiba H, Kamimura Y et al (2000) Expression of GFRalpha-1, receptor for GDNF, in rat brain capillary during postnatal development of the BBB. Am J Physiol Cell Physiol 279:361-368
18. Igarashi Y, Chiba H, Utsumi H et al (2000) Expression of receptors for glial cell line-derived neurotrophic factor (GDNF) and neurturin in the inner blood-retinal barrier of rats. Cell Struct Funct 25:237-241 (Pubitemid 32007607)
19. Sano Y, Shimizu F, Abe M et al (2010) Establishment of a new conditionally immortalized human brain microvascular endothelial cell line retaining an in vivo blood-brain barrier function. J Cell Physiol 225:519-528
20. Kashiwamura Y, Sano Y, Abe M et al (2011) Hydrocortisone enhances the function of the blood-nerve barrier through the up-regulation of claudin-5. Neurochem Res 36:849-855
21. Varley CL, Garthwaite MA, Cross W et al (2006) PPARgamma-regulated tight junction development during human urothelial cytodifferentiation. J Cell Physiol 208:407-417 (Pubitemid 43993431)
22. Ghassemifar MR, Eckert JJ, Houghton FD et al (2003) Gene expression regulating epithelial intercellular junction biogenesis during human blastocyst development in vitro. Mol Hum Reprod 9:245-252 (Pubitemid 36748827)
23. Zhang ZL, Liu ZS, Sun Q (2006) Expression of angiopoietins, Tie2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma. World J Gastroenterol 12:4241-4245 (Pubitemid 44376912)
24. Nitta T, Hata M, Gotoh S et al (2003) Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 161:653-660 (Pubitemid 36578587)
25. Ohtsuki S, Yamaguchi H, Katsukura Y et al (2008) mRNA expression levels of tight junction protein genes in mouse brain capillary endothelial cells highly purified by magnetic cell sorting. J Neurochem 104:147-154 (Pubitemid 350265064)
26. Honda M, Nakagawa S, Hayashi K et al (2006) Adrenomedullin improves the blood-brain barrier function through the expression of claudin-5. Cell Mol Neurobiol 26:109-118 (Pubitemid 43881818)
27. Bendfeldt K, Radojevic V, Kapfhammer J et al (2007) Basic fibroblast growth factor modulates density of blood vessels and preserves tight junctions in organotypic cortical cultures of mice: a new in vitro model of the blood-brain barrier. J Neurosci 27:3260-3267 (Pubitemid 46474137)
28. Argaw AT, Gurfein BT, Zhang Y et al (2009) VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci USA 106:1977-1982
29. Nishikiori N, Osanai M, Chiba H et al (2007) Glial cell-derived cytokines attenuate the breakdown of vascular integrity in diabetic retinopathy. Diabetes 56:1333-1340 (Pubitemid 46715614)
30. Kaur C, Ling EA (2008) Blood brain barrier in hypoxic-ischemic conditions. Curr Neurovasc Res 5:71-81 (Pubitemid 351302657)
31. Cirrito JR, Deane R, Fagan AM et al (2005) P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J Clin Invest 115:3285-3290 (Pubitemid 41567593)
32. Holman DW, Klein RS, Ransohoff RM (2011) The blood-brain barrier, chemokines and multiple sclerosis. Biochim Biophys Acta 1812:220-230
33. Lach B, Rippstein P, Atack D et al (1993) Immunoelectron microscopic localization of monoclonal IgM antibodies in gammopathy associated with peripheral demyelinative neuropathy. Acta Neuropathol 85:298-307 (Pubitemid 23081179)
34. Kanda T, Numata Y, Mizusawa H (2004) Chronic inflammatory demyelinating polyneuropathy: decreased claudin-5 and relocated ZO-1. J Neurol Neurosurg Psychiatry 75:765-769 (Pubitemid 38526691)
35. Giannini C, Dyck PJ (1995) Basement membrane reduplication and pericyte degeneration precede development of diabetic polyneuropathy and are associated with its severity. Ann Neurol 37:498-504
36. Shimizu F, Sano Y, Haruki H et al (2011) Advanced glycation end-products induce basement membrane hypertrophy in endoneurial microvessels and disrupt the blood-nerve barrier by stimulating the release of TGF-β and VEGF by pericytes. Diabetologia 54:1517-1526
37. Capowski EE, Schneider BL, Ebert AD et al (2007) Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy. J Neurosci Methods 163:338-349 (Pubitemid 46874594)
38. Hovland DN Jr, Boyd RB, Butt MT et al (2007) Six-month continuous intraputamenal infusion toxicity study of recombinant methionyl human glial cell line-derivedneurotrophic factor (r-metHuGDNF) in rhesus monkeys. Toxicol Pathol 35:1013-1029
39. Jakobsson J, Lundberg C (2006) Lentiviral vectors for use in the central nervous system. Mol Ther 13:484-493 (Pubitemid 43257616)
40. Wong LF, Goodhead L, Prat C et al (2006) Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications. Hum Gene Ther 17:1-9 (Pubitemid 43102718)
41. Cunningham LA, Su C (2002) Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease. Exp Neurol 174:230-242 (Pubitemid 34295786)
42. Pertusa M, García-Matas S, Mammeri H et al (2008) Expression of GDNF transgene in astrocytes improves cognitive deficits in aged rats. Neurobiol Aging 29:1366-1379 (Pubitemid 351970594)
43. Shen LH, Li Y, Chopp M (2010) Astrocytic endogenous glial cell derived neurotrophic factor production is enhanced by bone marrow stromal cell transplantation in the ischemic boundary zone after stroke in adult rats. Glia 58:1074-1081
44. Laganiere J, Kells AP, Lai JT et al (2010) An engineered zinc finger protein activator of the endogenous glial cell line-derived neurotrophic factor gene provides functional neuroprotection in a rat model of Parkinson's disease. J Neurosci 30:16469-16474